Exocytotic release of dopamine in ventral tegmental area slices from C57BL/6 and dopamine transporter knockout mice

Neurochemistry International

Volumn 49, Issue 8, 2006, Pages 737-745

  John, Carrie E ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Brain slices; Dopamine transporter; Dopamine transporter knockout mouse; Ventral tegmental area; Voltammetry

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 2 ETHYL 1,2,3,4,6,7 HEXAHYDRO 2 HYDROXY 3 ISOBUTYL 9,10 DIMETHOXY 11BH BENZO[A]QUINOLIZINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DESIPRAMINE; DOPAMINE; DOPAMINE TRANSPORTER; FLUOXETINE; NOMIFENSINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; TETRABENAZINE; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOPAMINE RELEASE; ELECTROSTIMULATION; EXOCYTOSIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; TRANSPORT KINETICS; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXOCYTOSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TETRABENAZINE; TETRODOTOXIN; VENTRAL TEGMENTAL AREA;

EID: 33750473732     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.06.004     Document Type: Article

References (84)

1. Abarca J., Gysling K., Roth R.H., and Bustos G. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies. Neurochem. Res. 20 (1995) 159-169
2. Aghajanian G.K., and Bunney B.S. Pharmacological characterization of dopamine "autoreceptors" by microiontophoretic single-cell recording studies. Adv. Biochem. Psychopharmacol. 16 (1977) 433-438
3. Agnati L.F., Zoli M., Stromberg I., and Fuxe K. Intercellular communication in the brain-wiring versus volume transmission. Neuroscience 69 (1995) 711-726
4. Bayer V.E., and Pickel V.M. Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabeling density and neuronal associations. J. Neurosci. 10 (1990) 2996-3013
5. Beckstead M.J., Grandy D.K., Wickman K., and Williams J.T. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42 (2004) 939-946
6. Bergquist F., Jonason J., Pileblad E., and Nissbrandt H. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J. Neurochem. 70 (1998) 1532-1540
7. Budygin E.A., John C.E., Mateo Y., Daunais J.B., Friedman D.P., Grant K.A., and Jones S.R. Chronic ethanol exposure alters presynaptic dopamine function in the striatum of monkeys: a preliminary study. Synapse 50 (2003) 266-268
8. Budygin E.A., John C.E., Mateo Y., and Jones S.R. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice. J. Neurosci. 22 RC222 (2002) 1-4
9. Cahill P.S., Walker Q.D., Finnegan J.M., Mickelson G.E., Travis E.R., and Wightman R.M. Microelectrodes for the measurement of catecholamines in biological systems. Anal. Chem. 68 (1996) 3180-3186
10. Carboni E., Spielewoy C., Vacca C., Nosten-Bertrand M., Giros B., and Di Chiara G. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J. Neurosci. 21 RC141 (2001) 1-4
11. Carboni E., Tanda G.L., Frau R., and Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55 (1990) 1067-1070
12. Chen B.T., Moran K.A., Avshalumov M.V., and Rice M.E. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release. J. Neurochem. 96 (2006) 645-655
13. 2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J. Neurosci. 21 (2001) 7841-7847
14. Chen B.T., and Rice M.E. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J. Neurochem. 81 (2002) 158-169
15. Cheramy A., Leviel V., and Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature 289 (1981) 537-542
16. Cobb W.S., and Abercrombie E.D. Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol. J. Neurosci. 22 (2002) 1407-1413
17. Cragg S.J., and Greenfield S.A. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J. Neurosci. 17 (1997) 5738-5746
18. Cragg S.J., Hawkey C.R., and Greenfield S.A. Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: region and species differences. J. Neurochem. 69 (1997) 2378-2386
19. Cragg S.J., Nicholson C., Kume-Kick J., Tao L., and Rice M.E. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J. Neurophysiol. 85 (2001) 1761-1771
20. Cragg S.J., and Rice M.E. DAncing past the DAT at a DA synapse. Trends Neurosci. 27 (2004) 270-277
21. Cragg S.J., Rice M.E., and Greenfield S.A. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. J. Neurophysiol. 77 (1997) 863-873
22. Cuello A.C. Storage and release of amines, amino acids and peptides from dendrites. Prog. Brain Res. 55 (1982) 205-224
23. Deutch A.Y., Goldstein M., Baldino Jr. F., and Roth R.H. Telencephalic projections of the A8 dopamine cell group. Ann. NY Acad. Sci. 537 (1988) 27-50
24. Elverfors A., Jonason J., Jonason G., and Nissbrandt H. Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices. Synapse 26 (1997) 359-369
25. Elverfors A., and Nissbrandt H. Reserpine-insensitive dopamine release in the substantia nigra?. Brain Res. 557 (1991) 5-12
26. Falkenburger B.H., Barstow K.L., and Mintz I.M. Dendrodendritic inhibition through reversal of dopamine transport. Science 293 (2001) 2465-2470
27. Garris P.A., Collins L.B., Jones S.R., and Wightman R.M. Evoked extracellular dopamine in vivo in the medial prefrontal cortex. J. Neurochem. 61 (1993) 637-647
28. Garris P.A., and Wightman R.M. In vivo voltammetric measurement of evoked extracellular dopamine in the rat basolateral amygdaloid nucleus. J. Physiol. 478 Pt 2 (1994) 239-249
29. Geffen L.B., Jessell T.M., Cuello A.C., and Iversen L.L. Release of dopamine from dendrites in rat substantia nigra. Nature 260 (1976) 258-260
30. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
31. Gonzalez-Hernandez T., Barroso-Chinea P., De L.C.M.I., Mar Perez-Delgado M., and Rodriguez M. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J. Comp. Neurol. 479 (2004) 198-215
32. Greenfield S.A. The significance of dendritic release of neurotransmitter and protein in the substantia nigra. Neurochem. Int. 7 (1985) 887-901
33. Groves P.M., and Linder J.C. Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections. Exp. Brain Res. 49 (1983) 209-217
34. Groves P.M., Wilson C.J., Young S.J., and Rebec G.V. Self-inhibition by dopaminergic neurons. Science 190 (1975) 522-528
35. Hausser M., Stuart G., Racca C., and Sakmann B. Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons. Neuron 15 (1995) 637-647
36. [3H]WIN35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the Fischer 344 rat. J. Pharmacol. Exp. Therapeut. 288 (1999) 1334-1339
37. Heeringa M.J., and Abercrombie E.D. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. J. Neurochem. 65 (1995) 192-200
38. Hoffman A.F., and Gerhardt G.A. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. J. Pharmacol. Exp. Therapeut. 289 (1999) 455-463
39. Ingram S.L., Prasad B.M., and Amara S.G. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5 (2002) 971-978
40. Iravani M.M., Muscat R., and Kruk Z.L. Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens. Neuroscience 70 (1996) 1025-1037
41. Jaber M., Dumartin B., Sagne C., Haycock J.W., Roubert C., Giros B., Bloch B., and Caron M.G. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 11 (1999) 3499-3511
42. Jaffe E.H., Marty A., Schulte A., and Chow R.H. Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices. J. Neurosci. 18 (1998) 3548-3553
43. Jimenez-Castellanos J., and Graybiel A.M. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience 23 (1987) 223-242
44. John C.E., Budygin E.A., Mateo Y., and Jones S.R. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. J. Neurochem. 96 (2006) 267-282
45. Jones S.R., Gainetdinov R.R., Hu X.T., Cooper D.C., Wightman R.M., White F.J., and Caron M.G. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2 (1999) 649-655
46. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., and Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 4029-4034
47. Jones S.R., Gainetdinov R.R., Wightman R.M., and Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18 (1998) 1979-1986
48. Jones S.R., Garris P.A., Kilts C.D., and Wightman R.M. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J. Neurochem. 64 (1995) 2581-2589
49. Jones S.R., Garris P.A., and Wightman R.M. Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Therapeut. 274 (1995) 396-403
50. Juraska J.M., Wilson C.J., and Groves P.M. The substantia nigra of the rat: a Golgi study. J. Comp. Neurol. 172 (1977) 585-600
51. Kalivas P.W., and Duffy P. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56 (1991) 961-967
52. 2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J. Physiol. 523 (2000) 163-173
53. Lacey M.G., Mercuri N.B., and North R.A. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J. Physiol. 392 (1987) 397-416
54. Llinas R.R. Depolarization-release coupling systems in neurons. Neurosci. Res. Prog. Bull. 15 (1977) 555-687
55. ++-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J. Pharmacol. Exp. Therapeut. 256 (1991) 1132-1138
56. Mateo Y., Budygin E.A., John C.E., Banks M.L., and Jones S.R. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens. J. Neurosci. Meth. 140 (2004) 183-187
57. Mateo Y., Budygin E.A., John C.E., and Jones S.R. Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 372-377
58. Mercer L., del Fiacco M., and Cuello A.C. The smooth endoplasmic reticulum as a possible storage site for dendritic dopamine in substantia nigra neurones. Experientia 35 (1979) 101-103
59. Near J.A., Bigelow J.C., and Wightman R.M. Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J. Pharmacol. Exp. Therapeut. 245 (1988) 921-927
60. Nieoullon A., Cheramy A., and Glowinski J. Release of dopamine in vivo from cat substantia nigra. Nature 266 (1977) 375-377
61. Nirenberg M.J., Chan J., Liu Y., Edwards R.H., and Pickel V.M. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J. Neurosci. 16 (1996) 4135-4145
62. Nirenberg M.J., Liu Y., Peter D., Edwards R.H., and Pickel V.M. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8773-8777
63. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., and Pickel V.M. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16 (1996) 436-447
64. Okuma Y., and Osumi Y. KCl-induced calcium-independent release of endogenous dopamine from rat brain slices. Brain Res. 363 (1986) 47-52
65. Palij P., and Stamford J.A. Real-time monitoring of endogenous noradrenaline release in rat brain slices using fast cyclic voltammetry. 3. Selective detection of noradrenaline efflux in the locus coeruleus. Brain Res. 634 (1994) 275-282
66. Pickel V.M., Garzon M., and Mengual E. Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron. Prog. Brain Res. 136 (2002) 145-155
67. Rice M.E., and Cragg S.J. Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7 (2004) 583-584
68. Rice M.E., Cragg S.J., and Greenfield S.A. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J. Neurophysiol. 77 (1997) 853-862
69. Rice M.E., Richards C.D., Nedergaard S., Hounsgaard J., Nicholson C., and Greenfield S.A. Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp. Brain. Res. 100 (1994) 395-406
70. Robertson G.S., Damsma G., and Fibiger H.C. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci. 11 (1991) 2209-2216
71. Robinson D.L., Venton B.J., Heien M.L., and Wightman R.M. Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo. Clin. Chem. 49 (2003) 1763-1773
72. Salvatore M.F., Apparsundaram S., and Gerhardt G.A. Decreased plasma membrane expression of striatal dopamine transporter in aging. Neurobiol. Aging 24 (2003) 1147-1154
73. Santiago M., Machado A., and Cano J. Fast sodium channel dependency of the somatodendritic release of dopamine in the rat's brain. Neurosci. Lett. 148 (1992) 145-147
74. Santiago M., and Westerink B.H. Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn-Schmiedeberg's Arch. Pharmacol. 342 (1990) 407-414
75. Santiago M., and Westerink B.H. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Eur. J. Pharmacol. 204 (1991) 79-85
76. Santiago M., and Westerink B.H. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat. Neurochem. Int. 20 Suppl. (1992) 107S-110S
77. 2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14 (1994) 88-106
78. Tagerud S.E., and Cuello A.C. Dopamine release from the rat substantia nigra in vitro. Effect of raphe lesions and veratridine stimulation. Neuroscience 4 (1979) 2021-2029
79. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. 367 Suppl. (1971) 1-48
80. Waszczak B.L., and Walters J.R. A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 105 (1984) 369-373
81. Westerink B.H., Santiago M., and De Vries J.B. In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 346 (1992) 637-643
82. Wilson C.J., Groves P.M., and Fifkova E. Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra. Exp. Brain Res. 30 (1977) 161-174
83. Woodward J.J., Chandler L.J., and Leslie S.W. Calcium-dependent and -independent release of endogenous dopamine from rat striatal synaptosomes. Brain Res. 473 (1988) 91-98
84. Wu Q., Reith M.E., Wightman R.M., Kawagoe K.T., and Garris P.A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. 112 (2001) 119-133